Comorbidities as a Personalized Target in Patients with Severe Asthma Treated with Dupilumab.

J Pers Med · 2025 · PMC12565378 · PMID 41149833

Europe PMC DOI

hedged sentence

0.2170

closest p · 4.3× alpha

0.2170

boldest claim

The sentences

did not reach statistical significancep = 0.217not close (p > 0.1)

19.8; p = 0.011), while the decrease in the number of exacerbations (from 3.0 to 1.3) did not reach statistical significance ( p = 0.217).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.